Search results
Study shows effectiveness of updated COVID-19 vaccines wanes moderately over time, is lower against...
Medical Xpress· 1 day agoPublished in the New England Journal of Medicine, the study found that COVID ...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 20 hours agoThe current COVID-19 boosters targeting the Omicron XBB.1.5 subvariant are still offering solid...
US approves Moderna's RSV vaccine for older adults
AFP via Yahoo News· 24 minutes agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 2 days agoThe updated monovalent XBB.1.5 COVID-19 vaccines were effective against Omicron subvariants circulating during the most...to 57.1% after 10 weeks, wrote...
Opinion | 'Still Haunted By His Pleas to Get Out of There': What We Heard This Week
MedPage Today· 5 days ago"I'm still haunted by his pleas to get out of there." -- Felice Freyer, president of the Association...
Monoclonal Antibody May Benefit Patients With Kidney Transplant Rejection
MedPage Today· 3 days agoOriginally developed for multiple myeloma, felzartamab is a fully human IgG1 monoclonal CD38...
Bird flu in Florida? Safe to consume chicken and milk? How the outbreak can affect you
Miami Herald via Yahoo News· 3 days agoThe study was recently published in the New England Journal of Medicine and “suggests that...
Scientists Decode Deadly Blood Clot Disorder Triggered by COVID Vaccines
SciTechDaily· 5 days agoNew research has shown that the dangerous PF4 antibodies involved in vaccine-induced thrombosis...
Antinephrin Autoantibodies: Biomarker for Kidney Disease?
Medscape· 5 days agoUsing an innovative analysis technique, researchers identified antinephrin autoantibodies as markers...
Dupilumab Improves Outcomes in COPD With Type 2 Inflammation
Medscape· 3 days agoNew trial confirmed safety and efficacy of a subcutaneous add-on therapy for uncontrolled COPD.